Inflammatory Bowel Diseases

Skip Navigation LinksHome > March 2013 - Volume 19 - Issue 3 > Prevention of Venous Thromboembolism in Hospitalized Patient...
Inflammatory Bowel Diseases:
doi: 10.1097/MIB.0b013e31827e7a0f
Cochrane Review

Prevention of Venous Thromboembolism in Hospitalized Patients With Inflammatory Bowel Disease

Chande, Nilesh MD

Collapse Box


Abstract: Venous thromboembolism is a relatively common and potentially serious complication in inpatients with inflammatory bowel disease (IBD). There are a number of pathophysiologic mechanisms for venous thromboembolism that are specific to patients with IBD that may be active. The use of anticoagulants for prophylaxis against venous thromboembolism in hospitalized patients with IBD needs to be balanced against the potential for worsening of rectal bleeding. Evidence from randomized trials suggests that heparin and low–molecular weight heparin are generally safe to use in patients with active IBD, and a number of guidelines support their use for thromboprophylaxis in this patient population.

© Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.